Table 7.
Comparison of Outcomes in Group A and Group B.
| Variable | Intention to treat analysis |
Per protocol analysis |
||||
|---|---|---|---|---|---|---|
| Group A N = 116 | Group B N = 58 |
P value | Group A N = 103 |
Group B N = 55 |
P value | |
| In-hospital mortality | 11 (9.4%) | 6 (10.34%) | 0.965a | 11 (10.67%) | 6.0 (10.09%) | 0.965a |
| Median duration of hospital stay, days (IQR) | 8.0 (5–11) | 8.0 (5.5–11) | 0.921c | 8.0 (6–11) | 8.0 (6–11.25) | 0.451c |
| Mortality by day 30 | 23 (19.8%) | 14 (24.1%) | 0.659a | 23 (22.3%) | 14 (25.4%) | 0.659a |
| Hypotension improved | 6/13 (46.1%) | 0/3 (0) | 0.250b | 6/12 (50%) | 0/3 (0%) | 0.229b |
| Sensorium improved | 20/34 (58.8%) | 14/22 (63.6%) | 0.719a | 20/34 (58.8%) | 14/22 (63.6%) | 0.719a |
| Serum creatinine improved | 68 (58.6%) | 36 (62.0%) | 0.813a | 68 (66.01%) | 36 (65.45%) | 0.813a |
| INR improved | 71 (61.2%) | 38 (65.5%) | 0.849a | 71 (68.9%) | 38 (69.09%) | 0.984a |
| Serum bilirubin improved | 64 (55.1%) | 37 (63.7%) | 0.522a | 64 (62.1%) | 37 (67.2%) | 0.522a |
INR = International normalized ratio; IQR = Interquartile range.
a
Chi square test.
b
Fischer's exact test.
c
Mann Whitney U Test.